Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Spagna
  4. Bolsas y Mercados Espanoles
  5. Oryzon Genomics S.A.
  6. SocietÓ
    ORY   ES0167733015

ORYZON GENOMICS S.A.

(ORY)
Prezzo in differita. Tempo differito Bolsas y Mercados Espanoles - 26/11 17:38:00
3.015 EUR   -3.98%
RiassuntoQuotazioniGraficiRatingAgendaSocietÓFinanzaConsensusRevisioniDerivati 
AttivitÓ
Logo Oryzon Genomics S.A.
Oryzon Genomics SA, is a Spain-based clinical phase biopharmaceutical company, which discovers and develops drugs based on epigenetics for the treatment of oncological and neurological diseases. Its compounds in clinical development include iadademstat (ORY-lOOl), an LSD1 inhibitor that is in Phase II trials for the treatment of acute myeloid leukemia and small cell lung cancer; and vafidemstat (ORY-2001), an LSD1 inhibitor optimized for the Central Nervous System (CNS), in multiple Phase II clinical trials for the treatment of CNS and psychiatric illnesses. The Company also has ORY-3001, in preclinical development for the treatment of non-oncological diseases and has additional programs to develop inhibitors against other epigenetic targets.
Dirigenti
Nome Titolo EtÓ Da
Carlos Manuel Buesa Arjol, Dr. Chairman, President & Chief Executive Officer - 2015
Enric Rello Condomines, Dr. Chief Operating & Financial Officer - -
Sonia Paloma Gutierrez Chief Clinical Operations - 2017
Jordi Xaus, Dr. Chief Scientific Officer - 2021
Xavier Perpinya Ribera Head-Internal Audit & Compliance - 2016
Antonio Fornieles Melero Lead Independent Director 60 2015
Isabel Aguilera Navarro Independent Director 60 2015
Ramˇn Adell Ramˇn, Dr. Independent Director - 2015
Manuel Lopez-Figueroa, Dr. Lead Independent Director - 2020
Emili Torrell Cortada Chief Business Development Officer - 2007
Amministratori
Nome Titolo EtÓ Da
Carlos Manuel Buesa Arjol, Dr. Chairman, President & Chief Executive Officer - 2015
Tamara Maes, Dr. First Deputy Chairman - 2020
Antonio Fornieles Melero Lead Independent Director 60 2015
Isabel Aguilera Navarro Independent Director 60 2015
Ramˇn Adell Ramˇn, Dr. Independent Director - 2015
Manuel Lopez-Figueroa, Dr. Lead Independent Director - 2020
Josep MarÝa Echarri Torres Director 45 2002
Azioni
Voto QuantitÓFlottanteAutocontrolloFlottante totale
Azione A 1 53 062 891 42 601 437 80.3% 301 337 0.6% 80.3%
Azionisti
NomeAzioni%
Carlos Manuel Buesa Arjol 3 507 457 6,61%
JosÚ-Maria Ventura Ferrero 2 907 846 5,48%
Tamara Maes 2 492 530 4,70%
Josep MarÝa Echarri Torres 1 026 928 1,94%
Andbank Wealth Management SGIIC SAU 577 079 1,09%
Gescooperativo SA SGIIC 348 570 0,66%
Oryzon Genomics S.A. 301 337 0,57%
Trea Asset Management SGIIC SA 218 178 0,41%
Solventis SGIIC SA 192 283 0,36%
Bankia Fondos SGIIC SA 139 999 0,26%
Partecipazioni
NomeAzioni%Valorizzazione
ORYZON GENOMICS S.A. (ORY) 301 337 0,57% 1 067 092 USD
Coordinate societÓ
Oryzon Genomics SA
Calle Sant Ferran 74
CornellÓ de Llobregat
Barcelona, Catalonia 08940

Phone : +34.93.515.13.13
Fax : +34.93.377.40.28
Web : http://www.oryzon.com
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pi¨ marchi di Oryzon Genomics S.A.
Settore Biotecnologia e ricerca medica - Altri